|
|
|
|
Peptic Ulcer Bacterium Alters The Body's Defence System
Helicobacter pylori survives in the body by manipulating important immune system cells.This is shown in a thesis from the Sahlgrenska Academy. The discovery may lead to new treatments against the common peptic ulcer...
|
|
|
Peptic ulcer bacterium alters the body's defence system
Helicobacter pylori survives in the body by manipulating important immune system cells.This is shown in a thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden. The discovery may lead to new treatments against the common...
|
|
|
Peptic ulcer bacterium alters the body's defense system
Helicobacter pylori survives in the body by manipulating important immune system cells.This is shown in a thesis from the Sahlgrenska Academy at the , Sweden. The discovery may lead to new treatments against the common peptic ...
|
|
|
H. pylori Alters the BodyEURs Defense System
Helicobacter pylori survives in the body by manipulating important immune system cells, according to new research from the Sahlgrenska Academy.The discovery may lead to new treatments against the common peptic ulcer bacterium....
|
|
|
Surgical Salvage of Bleeding Peptic Ulcers after Failed Therapeutic Endoscopy
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3.Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. Surgical Salvage...
|
|
|
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis
Heartburn and acid reflux are common medical disorders in pregnancy and can result in serious discomfort and complications, state the authors of this study.Furthermore, some pregnant women also experience more severe gastrointestinal...
|
|
|
Nexium IV licensed to reduce the risk of peptic ulcer rebleeding
Nexium IV (esomeprazole) has become the first and only proton pump inhibitor (PPI) to be licensed in Ireland for prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers, Astra Zeneca has...
|
|
|
Newly Presented Data On Gaster Show Prevention Of Peptic Ulcers In Users Of Low-dose Aspirine
(pdf 75KB) Prev Back to the list Next 2009 2008 2007 2006 2005 2004 Main Text end Message Business Philosophy VISION 2015 CSR-Based Management Governance & Internal Control Business Activities Corporate Profile Disclosure Policy News...
|
|
|
Self-Treatment Tips for Heartburn
Heartburn, the most common symptom of acid reflux, indigestion, and gastroesophageal reflux disease (GERD), also may occur with other diseases such as peptic ulcer disease.Heartburn is described as a substernal burning...
|
|
|
Helicobacter pylori infection and endocrine disorders: Is there a link
(Click the title below to leave the MDLinx Network and go to the Journal's Website) World Journal of Gastroenterology, 06/15/09 Print Save in My Library Free Full Text Papamichael KX et al.- Helicobacter pylori (H pylori) infection is a...
|
|
|
Missing link between stress and peptic ulcers discovered?
MedWire News: UK researchers may have revealed a missing link between stress and the development of peptic ulcers, after finding that norepinephrine stimulates the growth of Helicobacter pylori.Previous studies have showed...
|
|
|
Newly Presented Data On Gaster Show Prevention Of Peptic Ulcers In Users Of Low-Dose Aspirin
- Astellas Pharma Inc.(Headquarters: Tokyo; President and CEO: Masafumi Nogimori, hereinafter Astellas)today announced that the prevention of peptic ulcers in uses of low-dose aspirin was showed when they were treated with...
|
|
|
New Study Shows Nexium 40 Mg And 20 Mg Reduced Gastric And Duodenal Ulcers By 80 - 85% In Patients Taking Low-
Esomeprazole significantly reduced the occurrence of gastric and duodenal ulcers and upper gastrointestinal (GI) symptoms in patients taking low-dose aspirin for risk reduction of adverse cardiovascular (CV) events[i], such as...
|
|
|
Early Stage Data Confirms Desired Level Of Acid Suppression With Pn400 Formulation
New data presented today on the gastric acid suppression of investigational drug PN400 report that the formulation that combined an immediate release (IR) proton pump inhibitor (PPI) (esomeprazole 20 mg) with enteric coated (EC) naproxen ...
|
|
|
Newly Presented Data On Gaster Show Prevention Of Peptic Ulcers In Users Of Low-Dose Aspirin
- Astellas Pharma Inc.(Headquarters: Tokyo; President and CEO: Masafumi Nogimori, hereinafter Astellas)today announced that the prevention of peptic ulcers in uses of low-dose aspirin was showed when they were treated with...
|
|
|
American Society for Microbiology honors Mohamed A. Karmali
he 2009 (ASM) BD Award for Research in Clinical Microbiology is being presented to Mohamed A.Karmali, M.D., director-general of the Laboratory for Foodborne Zoonoses and Office of Biotechnology, Genomics, and Population Health, Public...
|
|
|
Health Buzz: Promising Breast Cancer Drugs and Other Health News
If breast cancer runs in your family, here are 7 things to consider.Also, check out 3 reasons not to panic if you're taking hormone replacement therapy. It's estimated that about 20 percent of the Western population experiences acid...
|
|
|
PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests
Company Expands Diagnostic Services with K9 Clone DOG-1 Immunohistochemical and H.pylori Monoclonal Antibody Tests LAKEWOOD, N.J., June 1 /PRNewswire/ -- PLUS Diagnostics, a leading U.S. anatomic pathology company offering a full range...
|
|
|
Has ISAAC told us as much as it can? Where now?
Martyn R Partridge Correspondence to: Professor Martyn R Partridge, Imperial College London, NHLI Division at Charing Cross Hospital, St Dunstans Road, London W6 8RP, UK; m.partridge@imperial.ac.uk The first 150 words of the full text of...
|
|
|
Eisai, GSK Collaborates For Paritec In India
Eisai India and GlaxoSmithKline (GSK) have signed an agreement to co-promote Paritec (rabeprazole sodium) in India.Paritecis, developed by Eisai, is a proton pump inhibitor, approved for the treatment of acid-related disorders like ...
|
|
|
Eisai, GSK Collaborates For Paritec In India
Eisai India and GlaxoSmithKline (GSK) have signed an agreement to co-promote Paritec (rabeprazole sodium) in India.Paritecis, developed by Eisai, is a proton pump inhibitor, approved for the treatment of acid-related disorders like ...
|
|
|
Eisai, GSK Collaborates For Paritec In India
Eisai India and GlaxoSmithKline (GSK) have signed an agreement to co-promote Paritec (rabeprazole sodium) in India.Paritecis, developed by Eisai, is a proton pump inhibitor, approved for the treatment of acid-related disorders like ...
|
|
|
Tarceva (erlotinib): serious adverse effects
Health Canada and Hoffmann-La Roche have issued an advisory concerning potentially serious adverse effects in association with erlotinib (Tarceva).These have included cases of gastrointestinal perforation (0.1-1.0% incidence); bullous,...
|
|
|
Takeda to integrate its Ireland subsidiaries
Takeda Ireland Limited and Takeda Pharma Ireland Limited merge operation on July 1, 2009 Suppliers to this Sector From the control room to the downstream processing ...IMCOR is an independent laboratory informatics con ... Cockburn...
|
|
|
Takeda to Integrate Its Two Manufacturing Operations in Ireland
--- Takeda Pharmaceutical Company Limited (Takeda) today announced the integration of its wholly owned subsidiaries Takeda Ireland Limited (TIL) (Kilruddery, Ireland) and Takeda Pharma Ireland Limited (TPI) (Dublin, Ireland) into a single...
|
